-
Published 5/15/2025
Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. Editor's Note: A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabine Chemoresistance in Pancreatic Adenocarcinoma Cells. Cancer Res. 2025 May 15; 85(10):1945. PMID: 40370067.
-
Published 5/15/2025
Ito H, Duxbury M, Benoit E, Clancy TE, Zinner MJ, Ashley SW, Whang EE. Retraction: Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Metalloproteinase-2. Cancer Res. 2025 May 15; 85(10):1947. PMID: 40370066.
-
Published 5/15/2025
Liau SS, Jazag A, Whang EE. Retraction: HMGA1 Is a Determinant of Cellular Invasiveness and In vivo Metastatic Potential in Pancreatic Adenocarcinoma. Cancer Res. 2025 May 15; 85(10):1946. PMID: 40370065.
-
Published 5/15/2025
Liau SS, Whang E. Editor's Note: HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma. Clin Cancer Res. 2025 May 15; 31(10):2064. PMID: 40370047.
-
Published 5/15/2025
Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. Editor's Note: RNA Interference Demonstrates a Novel Role for Integrin-Linked Kinase as a Determinant of Pancreatic Adenocarcinoma Cell Gemcitabine Chemoresistance. Clin Cancer Res. 2025 May 15; 31(10):2065. PMID: 40370046.